Thomas Kaley

11PUBLICATIONS
101CO-AUTHORS
Molecular targetsPredictive and prognostic markersChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

|May 11, 2026
Outcomes of inpatient chemoradiotherapy for patients with newly diagnosed glioblastoma and significant functional impairment.

|Aug 22, 2025
Multicenter basket trial for central nervous system tumors identifies activity of the CDK4/6 inhibitor abemaciclib in recurrent meningioma.

Thomas J Kaley, Christian Grommes, Elizabeth Coffee

|Jan 17, 2025
Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma.

Eudocia Q Lee, Brian M Alexander, Carlos G Romo

|Jul 12, 2024
A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma.

Christian Grommes, Subhiksha Nandakumar, Lauren R Schaff

|Sep 18, 2023
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization.

Rifaquat Rahman, Lorenzo Trippa, Eudocia Q Lee

Pageof 2

Frequent Collaborators

5 joint publications

Ingo K Mellinghoff

4 joint publications

Elena Pentsova

3 joint publications

Patrick Y Wen

3 joint publications

Keith L Ligon